UK says alternative to AstraZeneca vaccine advised for under-30s
Despite being ‘vanishingly rare’, serious brain blood-clotting has occurred in some who have received this Covid-19 shot
07 April 2021 - 17:59
London — Britain should give an alternative to Oxford-AstraZeneca’s Covid-19 vaccine to under-30s where possible due to a “vanishingly” rare side effect of blood clots in the brain, Britain’s vaccine advisory committee said on Wednesday.
Safety concerns have prompted more than a dozen countries in recent weeks to suspend use of the vaccine, which has been given to tens of millions of people in Europe, after reports linking it to a brain blood-clotting disorder in a few dozen recipients...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.